(Q33862414)

29 July 2017

A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. (English)

1 reference

29 July 2017

M A Hertzberg

1

1 reference

29 July 2017

M I Butterfield

2

1 reference

29 July 2017

M E Feldman

3

1 reference

29 July 2017

J C Beckham

4

1 reference

29 July 2017

S M Sutherland

5

1 reference

29 July 2017

K M Connor

6

1 reference

29 July 2017

J R Davidson

7

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 May 1999

1 reference

29 July 2017

Biological Psychiatry

1 reference

29 July 2017

45

1 reference

29 July 2017

1226-1229

1 reference

29 July 2017

9

1 reference

Psychobiologic mechanisms of posttraumatic stress disorder.

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900011-6

Validity and reliability of the DSM-III criteria for posttraumatic stress disorder. Experience with a structured interview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900011-6

Fluvoxamine in civilians with posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900011-6

7 January 2021

New antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900011-6

The use of anticonvulsants in posttraumatic stress disorder: case study and overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900011-6

Toward rational pharmacotherapy for posttraumatic stress disorder: an interim report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900011-6

Lamotrigine: an antiepileptic agent for the treatment of partial seizures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900011-6

Trial of trazodone for posttraumatic stress disorder using a multiple baseline group design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900011-6

Posttraumatic stress disorder in the National Comorbidity Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900011-6

Preliminary study of carbamazepine in post-traumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900011-6

An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900011-6

The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900011-6

Divalproex in posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900011-6

Posttraumatic stress disorder in Vietnam veterans clinical and EEG findings; possible therapeutic effects of carbamazepine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900011-6

Response characteristics to antidepressants and placebo in post-traumatic stress disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900011-6

Open trial of nefazodone for combat-related posttraumatic stress disorder.

7 January 2021

based on heuristic

deduced from DOI

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900011-6

10.1016/S0006-3223(99)00011-6

7 January 2021

based on heuristic

deduced from DOI

Identifiers

DOI

1 reference

29 July 2017

1 reference